Intrinsic Value of S&P & Nasdaq Contact Us

Neumora Therapeutics, Inc. Common Stock NMRA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.25
+251.9%

There have been 50 recent insider transactions recorded for Neumora Therapeutics, Inc. Common Stock (NMRA), including 8 buys and 38 sells. Total insider buying was valued at $25.95M and total insider selling at $29.22M.

Notable insiders with recent activity include Berns Paul L, Aurora Daljit Singh, Pinto Joshua. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — NMRA

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-02-17 Berns Paul L See Remarks Informative Sell 9,819 $3.51 $34.46K 7,395,185
2026-02-17 Aurora Daljit Singh See Remarks Informative Sell 6,165 $3.56 $21.92K 82,770
2026-02-17 Pinto Joshua President Informative Sell 5,967 $3.54 $21.09K 57,783
2026-02-17 Milligan Michael Lee See Remarks Informative Sell 1,436 $3.57 $5.12K 21,034
2026-01-08 Berns Paul L See Remarks RSU Award 1,650,000 $2.33 $3.84M 1,650,000
2026-01-08 Duncan Jason See Remarks RSU Award 750,000 $2.33 $1.75M 750,000
2026-01-08 Aurora Daljit Singh See Remarks RSU Award 750,000 $2.33 $1.75M 750,000
2026-01-08 Pinto Joshua President RSU Award 1,200,000 $2.33 $2.8M 1,200,000
2026-01-08 Milligan Michael Lee See Remarks RSU Award 350,000 $2.33 $815.5K 350,000
2025-11-11 Aurora Daljit Singh See Remarks Informative Sell 114,703 $2.68 $307.03K -
2025-10-27 Burow Kristina 10 Percent Owner Informative Buy 1,915,700 $2.61 $5M 6,046,907
2025-10-27 Arch Venture Partners X, Llc 10 Percent Owner Informative Buy 1,915,700 $2.61 $5M 6,046,907
2025-10-27 Arch Venture Partners Xii, Llc 10 Percent Owner Informative Buy 1,915,700 $2.61 $5M 6,046,907
2025-05-28 Berns Paul L See Remarks Return of Shares 2,000,000 $1.69 $3.38M -
2025-05-28 Fust Matthew K Director Return of Shares 28,571 $1.69 $48.28K -
2025-05-28 Burow Kristina 10 Percent Owner Return of Shares 28,571 $1.69 $48.28K -
2025-05-28 Piacquad David Director Return of Shares 28,571 $1.69 $48.28K -
2025-05-28 Ho Maykin Director Return of Shares 28,571 $1.69 $48.28K -
2025-05-28 Duncan Jason See Remarks Return of Shares 500,000 $1.69 $845K -
2025-05-28 Aurora Daljit Singh See Remarks Return of Shares 195,000 $1.69 $329.55K -
2025-05-28 Pinto Joshua President Return of Shares 3,000,000 $1.69 $5.07M -
2025-05-28 Halawa Alaa Director Return of Shares 28,571 $1.69 $48.28K -
2025-05-28 Milligan Michael Lee See Remarks Return of Shares 400,000 $1.69 $676K -
2025-05-21 Pinto Joshua President Gift (Given) 13,202 - - 63,750
2025-02-18 Berns Paul L See Remarks Informative Sell 13,871 $1.69 $23.47K 7,405,004
2025-02-18 Aurora Daljit Singh Chief Strategy Officer Informative Sell 8,565 $1.68 $14.35K 88,935
2025-02-18 Pinto Joshua President Informative Sell 8,048 $1.67 $13.48K 76,952
2025-02-18 Lenz Robert A. Head of R&d Informative Sell 5,614 $1.67 $9.38K 309,092
2025-02-18 Milligan Michael Lee See Remarks Informative Sell 1,978 $1.69 $3.35K 22,470
2025-02-13 Berns Paul L See Remarks Return of Shares 497,049 $4.63 $2.3M -
2025-02-13 Fust Matthew K Director Return of Shares 28,571 $9.95 $284.28K -
2025-02-13 Burow Kristina 10 Percent Owner Return of Shares 46,455 $17.00 $789.74K -
2025-02-13 Piacquad David Director Return of Shares 46,455 $17.00 $789.74K -
2025-02-13 Ho Maykin Director Return of Shares 28,571 $9.95 $284.28K -
2025-02-13 Duncan Jason See Remarks Return of Shares 400,000 $12.97 $5.19M -
2025-02-13 Aurora Daljit Singh See Remarks Return of Shares 195,000 $18.07 $3.52M -
2025-02-13 Pinto Joshua President Return of Shares 223,034 $2.51 $559.82K -
2025-02-13 Halawa Alaa Director Return of Shares 46,455 $17.00 $789.74K -
2025-02-13 Lenz Robert A. Head of R&d Return of Shares 100,000 $18.07 $1.81M -
2025-02-13 Milligan Michael Lee See Remarks Return of Shares 41,250 $18.07 $745.39K -
2024-12-27 Berns Paul L Director Gift (Given) 133,097 - - 7,418,875
2024-10-18 Fust Matthew K Director Option Exercise (Sell) 6,205 $8.79 $54.54K -
2024-10-17 Fust Matthew K Director Option Exercise (Sell) 3,783 $8.32 $31.47K -
2024-10-10 Lenz Robert A. Head of R&d Informative Sell 8,260 $15.09 $124.6K 314,706
2024-10-09 Lenz Robert A. Head of R&d Informative Sell 5,563 $15.01 $83.51K 322,966
2024-09-18 Lenz Robert A. Head of R&d Informative Sell 10,676 $12.09 $129.09K 328,529
2024-09-17 Lenz Robert A. Head of R&d Informative Sell 30,788 $11.81 $363.74K 339,205
2024-09-12 Aurora Daljit Singh Chief Strategy Officer Gift (Received) 29,737 $6.36 $189.13K 29,737
2024-09-12 Lenz Robert A. Head of R&d Informative Sell 32,948 $11.43 $376.66K 369,993
2023-12-11 Duncan Jason Officer Unknown - - - -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message